Kangchen Pharmaceutical announced that as of October 14, 2026, the company had completed the share repurchase. The actual share repurchase was 19.88 million shares, accounting for 1.24% of the company's total share capital. The repurchase price range was 28.36 yuan/share - 51.40 yuan/share. The average repurchase price was 39.24 yuan/share, and the total payment amount was 784.3339 million yuan. All of the shares repurchased will be used for employee stock ownership plans or equity incentives. The company must complete the grant or transfer within three years after disclosing the repurchase results, and those not used up will be cancelled.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.